LYMPHOMA, B-CELL, MARGINAL ZONE
Clinical trials for LYMPHOMA, B-CELL, MARGINAL ZONE explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMA, B-CELL, MARGINAL ZONE trials appear
Sign up with your email to follow new studies for LYMPHOMA, B-CELL, MARGINAL ZONE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising new combo aims to tame rare lymphoma with less radiation
Disease control OngoingThis study tests a two-step treatment for people with early-stage MALT lymphoma, a slow-growing cancer of the lymph nodes. First, patients take a targeted drug called orelabrutinib. Then, based on how well the tumor responds, they receive an ultra-low dose of radiation (4Gy). The…
Matched conditions: LYMPHOMA, B-CELL, MARGINAL ZONE
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New pill shows promise in battling advanced blood cancers
Disease control OngoingThis early-stage study tests an experimental pill called LOXO-338 in people with advanced blood cancers (like certain leukemias, lymphomas, and multiple myeloma) who have already tried standard treatments. The main goals are to find the safest dose and to see if the drug can shri…
Matched conditions: LYMPHOMA, B-CELL, MARGINAL ZONE
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 12, 2026 13:51 UTC